4-Isopropylidenamino-morpholin | 41482-88-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-Isopropylidenamino-morpholin
• 英文别名: isopropylidene-morpholin-4-yl-amine；N-(Morpholin-4-yl)propan-2-imine；N-morpholin-4-ylpropan-2-imine
• CAS: 41482-88-6
• 化学式: C₇H₁₄N₂O
• 分子量: 142.201
• InChiKey: DIOUFZAQZGBPHJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  24.8
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• 4-(2-AMINO-TETRAHYDRONAPHTHALENYL)PYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING SAME AS ACTIVE INGREDIENT
  申请人：KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY

  公开号：US20180104242A1

  公开（公告）日：2018-04-19

  The present invention relates to a 4-(2-amino-tetrahydronaphthaleneyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The 4-(2-amino-tetrahydronaphthaleneyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.

  本发明涉及一种4-(2-氨基-四氢萘基)嘧啶衍生物，其制备方法以及包含其作为活性成分的用于预防或治疗癌症的药物组合物。本发明的4-(2-氨基-四氢萘基)嘧啶衍生物及其光学异构体或其药用可接受的盐对抑制间变性淋巴瘤激酶（ALK）活性非常有效，从而可以提高对具有间变性淋巴瘤激酶（ALK）融合蛋白如EML4-ALK和NPM-ALK的癌细胞的治疗效果，因此可以有效地作为预防或治疗癌症的药物组合物使用。
• 5-PHENYLPYRIMIDINES, THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE
  申请人：GYPSER Andreas

  公开号：US20070149551A1

  公开（公告）日：2007-06-28

  5-Phenylpyrimidines of the formula I in which the substituents and the index are as defined below: R 1 ,R 2 are hydrogen, alkyl, haloalkyl, cycloalkyl, halocycloalkyl, alkenyl, haloalkenyl, alkynyl or haloalkynyl, and R 1 and R 2 together with the nitrogen atom to which they are attached may also form a saturated or unsaturated ring which may be interrupted by an ether, thio, sulfoxyl or sulfonyl group and may be substituted by one to four groups R a and/or R b ; R 3 is hydrogen, halogen, cyano, alkyl, haloalkyl, alkoxy, haloalkoxy or alkenyloxy; R 4 is hydrogen, halogen, cyano, hydroxyl, mercapto, azido, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, alkenyloxy, alkynyloxy, haloalkoxy, alkylthio, alkenylthio, alkynylthio, haloalkylthio, —ON═CRN a R b , —CR c ═NOR a , —NR c N═CR a R b , —NR a R b , —NR c NR a R b , —NOR a , —NR c C (═NR c′ )NR a R b , —NR c C(═O)NR a R b , —NR a C(═O)R c , —NR a C(═NOR c )R c′ , —OC (═O)R c , —C(═NOR c )NR a R b , —CR c (═NNR a R b ), —C (═O)NR a R b or —C(═O) R c ; in which R a , R b and R c are as defined in the description; X is halogen, alkyl, alkoxy or haloalkyl; and m is an integer from 1 to 5; processes for preparing these compounds, compositions comprising them and their use for controlling harmful fungi are described.

  公式I中的5-苯基嘧啶化合物，其中取代基和指数定义如下：R1、R2为氢、烷基、卤代烷基、环烷基、卤代环烷基、烯基、卤代烯基、炔基或卤代炔基，且R1和R2与它们附着的氮原子也可以形成饱和或不饱和环，该环可以被醚、硫、亚硫酰基或磺酰基中断，并且可以被一个到四个基团Ra和/或Rb取代；R3为氢、卤素、氰基、烷基、卤代烷基、烷氧基、卤代烷氧基或烯氧基；R4为氢、卤素、氰基、羟基、巯基、叠氮基、烷基、烯基、炔基、卤代烷基、烷氧基、烯氧基、炔氧基、卤代烷氧基、烷硫基、烯硫基、炔硫基、卤代烷硫基、-ON═CRNaRb，-CRc═NORa，-NRcN═CRaRb，-NRaRb，-NRcNRaRb，-NORa，-NRcC（═NRc'）NRaRb，-NRcC（═O）NRaRb，-NRaC（═O）Rc，-NRaC（═NORc）Rc'，-OC（═O）Rc，-C（═NORc）NRaRb，-CRc（═NNRaRb），-C（═O）NRaRb或-C（═O）Rc；其中Ra、Rb和Rc如描述中所定义；X为卤素、烷基、烷氧基或卤代烷基；m为1至5的整数；描述了制备这些化合物的过程、包含它们的组合物以及它们用于控制有害真菌的用途。
• Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
  申请人：Ito Mashito

  公开号：US20070167421A1

  公开（公告）日：2007-07-19

  This invention relates to an agrohorticultural fungicide containing benzylpyrimidine derivatives represented by the formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined in the disclosure.

  本发明涉及一种农业园艺用杀菌剂，其包含由以下式表示的苯基嘧啶衍生物：其中R1、R2、R3、R4、R5和R6如说明书所定义。
• 4-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredient
  申请人：KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY

  公开号：US10369149B2

  公开（公告）日：2019-08-06

  The present invention relates to a 4-(2-amino-tetrahydronaphthaleneyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The 4-(2-amino-tetrahydronaphthaleneyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.

  本发明涉及一种 4-(2-氨基-四氢萘基)嘧啶衍生物、其制备方法和一种预防或治疗癌症的药物组合物，其有效成分包括 4-(2-氨基-四氢萘基)嘧啶衍生物。本发明的 4-(2-氨基-四氢萘基)嘧啶衍生物、其光学异构体或其药学上可接受的盐在抑制无性淋巴瘤激酶（ALK）活性方面非常有效，因此可以提高对具有无性淋巴瘤激酶（ALK）融合蛋白（如 EML4-ALK 和 NPM-ALK）的癌细胞的治疗效果，从而可以有效地用作预防或治疗癌症的药物组合物。
• HERBICIDAL SUBSTITUTED 3-ARYLPYRAZOLES
  申请人：E I DU PONT DE NEMOURS AND COMPANY

  公开号：US20170183312A1

  公开（公告）日：2017-06-29

  Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein X 1 , X 2 , X 3 , G and Q are as defined in the Summary of the Invention; P is P 1 or P 2 ; and P 1 and P 2 are as defined in the Summary of the Invention. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention. Also disclosed is a herbicidal mixture comprising (a) a compound of Formula 1, and (b) at least one additional active ingredient selected from (b1) through (b16); and salts of compounds of (b1) through (b16), wherein (b1) through (b16) are as defined in the disclosure.